Showing results (11-20 of 65) with videos related to
Sort By:
Pageof 7
Zeitschrift Fur Gastroenterologie|January 22, 2009
[Sorafenib for the treatment of HCC--the beginning of a new era in the treatment of HCC]T F Greten, M P Manns, N MalekCurrent Opinion in Immunology|October 1, 1996
Murine tumor antigens: is it worth the search?E M Jaffee, D M PardollOncology (Williston Park, N.Y.)|March 29, 2000
Potential role of tumor vaccines in GI malignanciesD A Laheru, E M JaffeeMethods (San Diego, Calif.)|June 1, 1997
Considerations for the clinical development of cytokine gene-transduced tumor cell vaccinesE M Jaffee, D M PardollMinerva Endocrinologica|April 14, 2010
Molecular therapy of pancreatic cancerR R Plentz, M P Manns, T F GretenCancer Journal (Sudbury, Mass.)|September 20, 2001
Immunologic approaches to the management of pancreatic cancerD Laheru, B Biedrzycki, E M JaffeeNatural Immunity|January 1, 1992
The development and characterization of a natural killer cell-resistant human renal cell carcinoma cell lineM S Ernstoff, E M Jaffee, T OelerZeitschrift Fur Gastroenterologie|January 7, 2006
[Treatment of hepatocellular carcinoma]T F Greten, H E Blum, M P Manns, et al.European Journal of Pharmacology|March 28, 1996
Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-alpha synthesisT F Greten, B Sinha, C Haslberger, et al.European Journal of Gastroenterology & Hepatology|July 1, 1996
Synthesis of tumour necrosis factor-alpha in tissue culture of rat caecum: lack of suppression by phosphodiesterase inhibitors and prostanoidsT F Greten, J Moeller, H Feldmeier, et al.Pageof 7